ARCHIVES

FDA, NIH Streamline Approvals For Gene Therapy Studies

This article is from The Cancer Letter archive.

Vol. 21 No. 24 | June 16, 1995

Download PDF Visit The Full Archive

Related Articles

HCFA Draft Document Dampens Jubilation Over Clinton Plan To Pay Patient Care Costs.

June 16, 2000

Atrix, Sanofi In Marketing Deal For Leuprogel Products.

January 26, 2001

Breast Cancer Risk Prediction Improved In Atypia Cases

July 27, 2007

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

HAS Authority Over Cancer Program Become Hot Issues; Fredrickson Opposes Exemption For NCI

October 29, 1976

Full Funding Of Indirect Costs, Other Mandates By Congress Chew Up Most Of NCI’s Extra Money

December 2, 1983